Discovery To Commence In Invitrogen Patent Case
Life sciences company Invitrogen Corp. has won the go-ahead to commence limited discovery in a lawsuit that accuses Harvard College's top guardians of wrongly laying claim to a molecular cloning patent....To view the full article, register now.
Already a subscriber? Click here to view full article